NACE Rev. 2.1 · Class · Section C
21.10 Manufacture of basic pharmaceutical products
It includes manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids); processing of blood.
- Level
- Class
- NACE Rev. 2
- 21.10
- TOL 2025 (FI)
- 21100
- Active companies
- 645
What 21.10 covers
Includes
- manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids)
- processing of blood
Also includes
- manufacture of chemically pure sugars
- manufacture of probiotics
- processing of glands and manufacture of extracts of glands, etc.
Classified elsewhere
Excludes
- manufacture of advanced cell and gene therapy pharmaceutical preparations, see 21.20
Also searched as
- pharma
- pharmaceutical
- biotech
- biotechnologie
- biotechnology
- bioteknologia
Plain-language terms that lookup_industry maps to this code.
National codes for 21.10
Every EU country uses NACE Rev. 2.1 as its national classification, sometimes with an extra national level. The first four digits of a national code always equal the NACE class, so a company coded under any of the patterns below belongs to 21.10.
| Country | Classification | Code | Local title |
|---|---|---|---|
| France | NAF 2025 INSEE | 21.10A–Z NACE class + 1 letter | Fabrication de produits pharmaceutiques de base |
| Sweden | SNI 2025 Statistics Sweden (SCB) | 21100–9 5 digits: NACE class + 1 digit | Tillverkning av farmaceutiska basprodukter |
| Belgium | NACE-BEL 2025 Statbel | 21.100–9 5 digits: NACE class + 1 digit | Vervaardiging van farmaceutische grondstoffen |
| Czech Republic | CZ-NACE 2025 Czech Statistical Office (ČSÚ) | 2110(0–9) NACE class, some split by a 5th digit | Výroba základních farmaceutických výrobků |
| Finland | TOL 2025 Statistics Finland | 21100 One subclass | Lääkeaineiden valmistus |
| Estonia | EMTAK 2025 Statistics Estonia | 21100–9 5 digits: NACE class + 1 digit | Põhifarmaatsiatoodete tootmine |
Local titles are the official NACE Rev. 2.1 translations; national tables can word them slightly differently. Belgium is shown with the Dutch title (French in the translations table).
TOL 2025 subclasses (Finland)
- 21100 Lääkeaineiden valmistus Manufacture of basic pharmaceutical products
21.10 in other EU languages
The official title of NACE 21.10 in each language version of NACE Rev. 2.1.
| Language | Title |
|---|---|
| French France (NAF), Belgium (NACE-BEL) | Fabrication de produits pharmaceutiques de base |
| German Germany (WZ), Austria (ÖNACE) | Herstellung von pharmazeutischen Grundstoffen |
| Swedish Sweden (SNI) | Tillverkning av farmaceutiska basprodukter |
| Finnish Finland (TOL) | Lääkeaineiden valmistus |
| Czech Czech Republic (CZ-NACE) | Výroba základních farmaceutických výrobků |
| Estonian Estonia (EMTAK) | Põhifarmaatsiatoodete tootmine |
| Dutch Belgium (NACE-BEL), Netherlands (SBI) | Vervaardiging van farmaceutische grondstoffen |
| Danish Denmark (DB) | Fremstilling af farmaceutiske råvarer |
| Spanish Spain (CNAE) | Fabricación de productos farmacéuticos de base |
| Italian Italy (ATECO) | Fabbricazione di prodotti farmaceutici di base |
| Polish Poland (PKD) | Produkcja podstawowych substancji farmaceutycznych |
| Portuguese Portugal (CAE) | Fabricação de produtos farmacêuticos de base |
What changed from NACE Rev. 2
Unchanged from Rev. 2NACE Rev. 2.1 replaced Rev. 2 in EU statistics from 2025, and national registers are recoding companies to it. These Rev. 2 codes map to 21.10, according to Eurostat’s official correspondence table:
-
Rev. 2 21.10 Manufacture of basic pharmaceutical products maps entirely here
What moved to 21.10:
- manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products, e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids - processing of blood - manufacture of chemically pure sugars - manufacture of probiotics - processing of glands and manufacture of extracts of glands
Companies under 21.10
Active legal entities whose main activity is 21.10, from the official business registers. Refreshed daily; sole traders are not included.
Total: 645. A dash means no companies with this main activity in the index yet.
Find 21.10 companies from Claude
EU Company Leads is an MCP server. Your agent resolves the industry with lookup_industry, then lists companies with search_companies, filtered by size, age, region and more.
1 · lookup_industry
{
"query": "pharma"
}
2 · search_companies
{
"nace_codes": [
"21.10"
],
"countries": [
"BE",
"FR"
],
"limit": 25
}
Questions about NACE 21.10
What is NACE 21.10?
NACE 21.10 is the class “Manufacture of basic pharmaceutical products” in NACE Rev. 2.1, the EU statistical classification of economic activities, part of group 21.1 (Manufacture of basic pharmaceutical products), in division 21 (Manufacture of basic pharmaceutical products and pharmaceutical preparations), in section C (Manufacturing). It includes manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids); processing of blood.
Which NACE code is used for manufacture of advanced cell and gene therapy pharmaceutical preparations?
Manufacture of advanced cell and gene therapy pharmaceutical preparations is classified in NACE 21.20 (Manufacture of pharmaceutical preparations), not in 21.10, according to the Eurostat explanatory notes for NACE Rev. 2.1.
What is the national equivalent of NACE 21.10 in France, Sweden, Belgium, Czech Republic, Finland and Estonia?
All six keep the NACE class 21.10 and add at most one national position. NAF 2025 (France) writes it as 21.10 followed by one letter; SNI 2025 (Sweden), NACE-BEL 2025 (Belgium) and EMTAK 2025 (Estonia) use five digits beginning with 2110; CZ-NACE 2025 (Czech Republic) uses 2110, split by a fifth digit in some classes; TOL 2025 (Finland) uses 21100. The first four digits always equal the NACE class.
What was the NACE Rev. 2 code for NACE 21.10?
The code is unchanged: NACE Rev. 2 21.10 (Manufacture of basic pharmaceutical products) maps one-to-one to 21.10 in NACE Rev. 2.1.
How many companies are registered under NACE 21.10?
EU Company Leads holds 645 active companies whose main activity is 21.10: Belgium 356, France 226, Sweden 22, Finland 16, Estonia 14, Czech Republic 11. Counts come from the official business registers and are refreshed daily; sole traders are not included.
Headings, explanatory notes, translations and the Rev. 2 → Rev. 2.1 correspondence: © European Union, Eurostat, NACE Rev. 2.1, licensed under CC BY 4.0; formatted and linked by EU Company Leads. TOL 2025 subclasses: Statistics Finland, CC BY 4.0. Company counts: official national business registers.